Showing 1 - 10 of 6,669
Persistent link: https://www.econbiz.de/10011606135
Persistent link: https://www.econbiz.de/10012663313
Persistent link: https://www.econbiz.de/10011660160
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is … also characterized by extensive regulation of almost every activity, from product development through manufacturing and … research and incentives for innovation. We then summarize the pricing and marketing of drugs in the US and several other …
Persistent link: https://www.econbiz.de/10014025576
pharmaceuticals. The changing methods by which drugs are discovered, the links between companies and academic science, the changing … character of public regulation, and the sharp rise in the cost per new approved drug are analyzed. Determining which new drugs …
Persistent link: https://www.econbiz.de/10014025164
Persistent link: https://www.econbiz.de/10002795484
Persistent link: https://www.econbiz.de/10012816525
The rise of blockbuster pharmaceutical acquisitions has prompted fears that unprecedented market concentration will weaken competition. Two of the most prominent concerns focus on the upstream and downstream ends of the pharmaceutical industry: (1) the concern that these mergers will concentrate...
Persistent link: https://www.econbiz.de/10011721586
Persistent link: https://www.econbiz.de/10013433326
Persistent link: https://www.econbiz.de/10013179155